Berkshire Biomedical, which develops a cellular-connected device for dispensing medicine, raised $3 million in a funding round from accredited investors. The company’s flagship product under
Berkshire Biomedical, which develops a cellular-connected device for dispensing medicine, raised $3 million in a funding round from accredited investors. The company’s flagship product under